In bladder cancer, CXCL12 upregulates the deubiquitinating enzyme CYLD through the JAK2/STAT3 signalling pathway, and CYLD inhibits autophagy in bladder cancer by inducing the accumulation of P62 through deubiquitination of P62.80 Here, JAK2 is linked to urinary bladder cancer.